HMGB2 knockdown ameliorates retinal ganglion cell injury by inhibiting NLRP3 inflammasome activation after retinal ischemia

<i>HMGB2</i> knockdown protects against RGC apoptosis and pyroptosis after RIRI through suppressing NLRP3 inflammasome activation.

Authors

Institutions

Publication Details

Journal
International Journal of Ophthalmology
Published
2024-12-18
DOI
https://doi.org/10.18240/ijo.2025.01.05
Primary Topic
Advanced Glycation End Products research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HMGB2 knockdown ameliorates retinal ganglion cell injury by inhibiting NLRP3 inflammasome activation after retinal ischemia

Long-xing Xue
International Journal of Ophthalmology
Advanced Glycation End Products research
article

HMGB2 knockdown ameliorates retinal ganglion cell injury by inhibiting NLRP3 inflammasome activation after retinal ischemia

Long-xing Xue
article en

Abstract

<i>HMGB2</i> knockdown protects against RGC apoptosis and pyroptosis after RIRI through suppressing NLRP3 inflammasome activation.

International Journal of OphthalmologyVol. 18(1)
Hubei University of Chinese Medicine (CN)
Hubei Provincial Department of Education
Openalex Percentile: Top 66%
Advanced Glycation End Products research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

HMGB2 knockdown ameliorates retinal ganglion cell injury by inhibiting NLRP3 inflammasome activation after retinal ischemia — Long-xing Xue · International Journal of Ophthalmology (2024) | TGRS Research Map | TGRS